Respiratory News and Research

RSS

Innovative T-shirt monitors wearer's respiratory rate in real time

Researchers at Université Laval's Faculty of Science and Engineering and its Center for Optics, Photonics, and Lasers have created a smart T-shirt that monitors the wearer's respiratory rate in real time.

18 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

University of Guelph researcher discovers effective way to treat shortness of breath in heart failure

Shortness of breath is the No.1 complaint of people suffering from heart failure. Now a University of Guelph researcher has discovered its surprising cause - and an effective treatment - in a groundbreaking new study.

17 May 2017

Recovery from bacterial pneumonia changes the infected lung cells, study shows

When people develop a respiratory infection, recovery from their illness leaves behind an immunological memory that influences how they will respond to later infections.

17 May 2017

Common antidepressant use during pregnancy linked to increased risk of malformations in infants

Use of fluoxetine-the most commonly prescribed antidepressant-during pregnancy is linked with a slightly increased risk of malformations in infants, according to a recent analysis of published studies.

17 May 2017

New research could be first step toward drug to treat Zika infections

New research led by Alexey Terskikh, Ph.D., associate professor at Sanford Burnham Prebys Medical Discovery Institute (SBP), and Alex Strongin, Ph.D., professor at SBP, could be a first step toward a drug to treat Zika infections. Publishing in Antiviral Research, the scientific team discovered a compound that prevents the virus from spreading.

16 May 2017

WHO finds 1.2 million adolescent deaths annually, mostly from preventable causes

A new report from the World Health Organization (WHO) and partners find that adolescent deaths amount to more than 3000 a day, which totals to 1.2 million deaths annually that are mostly from preventable or treatable causes. In low- and middle-income countries of the African and Southeast Asian regions, 855, 000 adolescents in the age group of 10–19-years old died in the year 2015. Road traffic injuries being the leading cause of death, and other major causes of deaths in adolescent are due to lower respiratory infections and suicide.

16 May 2017

New report reveals that 1.2 million adolescents die every year from preventable causes

More than 3000 adolescents die every day, totaling 1.2 million deaths a year, from largely preventable causes, according to a new report from the World Health Organization and partners.

16 May 2017

UBC researchers uncover potential adverse reactions of common multiple sclerosis drug

In one of the most comprehensive studies to date, UBC researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug.

15 May 2017

Preclinical data reinforces potential efficacy, durability of investigational gene therapy for DMD

Solid Biosciences announced today that new data from two preclinical studies reinforce the potential of its investigational microdystrophin gene therapy, SGT-001, to be an effective treatment approach for Duchenne muscular dystrophy.

11 May 2017

CUMC researchers create new organoids that mimic features of full-sized lung

New lung "organoids"-tiny 3-D structures that mimic features of a full-sized lung- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center. The team used the organoids to generate models of human lung diseases in a lab dish, which could be used to advance our understanding of a variety of respiratory diseases.

11 May 2017

Researchers identify cells that drive autoimmune disease

Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis.

11 May 2017

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory syncytial virus (RSV), the virus that causes croup and lower respiratory infections. RSV kills about 160,000 people, primarily infants, worldwide each year.

10 May 2017

Sleep: perception and prioritization

The international survey on sleep that was recently conducted by Harris Poll on behalf of Philips, was conducted to support World Sleep Day and the activities across the globe carried out on this day were to increase awareness of the importance of sleep health.

From Philips Healthcare 10 May 2017

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Nearly one in two seniors in Ontario who visited a family doctor for a non-bacterial infection received an unnecessary antibiotic prescription, according to a new study from the Institute for Clinical Evaluative Sciences Western site in London, Ontario and Lawson Health Research Institute.

9 May 2017

Peer victimization in fifth grade has lasting effects on health and later substance use, study finds

A new study led by the University of Delaware found that kids who are bullied in fifth grade often suffer from depression and begin using alcohol and other substances a few years after the incidents.

8 May 2017

FDA approves new treatment for people with ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.

5 May 2017

FDA approves new AML drug after clinical testing at Dana-Farber

A targeted drug whose clinical testing was led by Richard Stone, MD, of Dana-Farber Cancer Institute, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.

5 May 2017

Scientists identify differences in outcomes for women and men with AFF in emergency departments

Atrial fibrillation and flutter (also known as AFF) is associated with serious health problems and is a significant contributor to death rates.

4 May 2017

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD), published today in the European Respiratory Journal, has revealed that both the 3-year all-cause mortality rate and financial burden for patients with the disease is almost four times higher than a matched control group.

2 May 2017

Respiratory News and Research

Innovative T-shirt monitors wearer's respiratory rate in real time

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

University of Guelph researcher discovers effective way to treat shortness of breath in heart failure

Recovery from bacterial pneumonia changes the infected lung cells, study shows

Common antidepressant use during pregnancy linked to increased risk of malformations in infants

New research could be first step toward drug to treat Zika infections

WHO finds 1.2 million adolescent deaths annually, mostly from preventable causes

New report reveals that 1.2 million adolescents die every year from preventable causes

UBC researchers uncover potential adverse reactions of common multiple sclerosis drug

Preclinical data reinforces potential efficacy, durability of investigational gene therapy for DMD

CUMC researchers create new organoids that mimic features of full-sized lung

Researchers identify cells that drive autoimmune disease

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

Sleep: perception and prioritization

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Peer victimization in fifth grade has lasting effects on health and later substance use, study finds

FDA approves new treatment for people with ALS

FDA approves new AML drug after clinical testing at Dana-Farber

Scientists identify differences in outcomes for women and men with AFF in emergency departments

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News